Why Clinicians Need to Know the Challenges Associated with Getting AST Results
AUG 12, 2017 | CONTAGION® EDITORIAL STAFF
Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, clinical professor of pharmacy practice, Temple University, explains why clinicians should be aware of the challenges associated with getting antimicrobial susceptibility testing results available.
Interview Transcript (slightly modified for readability)
“It’s important that clinicians make others aware of the challenges that are out there in getting antimicrobial susceptibility testing results available, particularly for new drugs. The delays that exist from the drug approval to tests being approved has significantly impacted our ability to use those drugs, and we all have to understand that they exist. [We also need to be aware of] the challenges they incur on the microbiology lab to manually do some of those tests that can’t be done in the normal, easy ways that we generally depend upon.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512